FIELD: technological processes; pharmacology.
SUBSTANCE: antagonist of human interleukine-1 receptor is prepared with the help of recombinant strain E. coli that contains plasmid, which provides production of this protein. For this purpose the strain is cultivated. Then from bacterial cells the target product is separated with application of three-stage chromatography and concentration on hydrophobic sorbent. At that the first and the third stage of mentioned chromatographic purification is performed on cation-exchanging resin, and in the second stage of chromatography the anion-exchanging resin is used.
EFFECT: application of invention allows to prepare antagonist of human receptor of high purity.
7 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING INTERLEUKIN-1-BETA PREPARATION | 2002 |
|
RU2234513C2 |
METHOD FOR PURIFICATION OF RECOMBINANT IL-36RA (EMBODIMENTS) | 2018 |
|
RU2700751C1 |
PLASMID VECTOR PRH15A FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B, BACTERIAL STRAIN ESCHERICHIA COLI BL21 DE3 - PRODUCER OF METHIONINE-FREE INTERFERON ALPHA-2B AND METHOD FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B | 2017 |
|
RU2697375C2 |
METHOD OF ISOLATION OF SUPEROXIDE DISMUTASE | 2001 |
|
RU2186848C1 |
METHOD FOR PREPARING RECOMBINANT INTERFERON ALPHA-2b AND INTERFERON-CONTAINING PREPARATION (VARIANTS) | 2005 |
|
RU2294372C1 |
CELLULOSE DIETHYLAMINOETHYL ETHER AS SORBENT FOR RECOVERY AND PURIFICATION OF ENZYME PREPARATIONS AND PROCESS FOR PURIFICATION OF STREPTOKINAZE | 1993 |
|
RU2076870C1 |
METHOD OF INDUSTRIAL PURIFICATION OF ROMIPLOSTIM | 2021 |
|
RU2804622C2 |
METHOD FOR PREPARING, ISOLATING, PURIFYING AND STABILIZING HUMAN RECOMBINANT GRANULOCYTIC COLONY-STIMULATING FACTOR USEFUL FOR MEDICINAL USING AND IMMUNOBIOLOGICAL AGENT BASED ON THEREOF | 2004 |
|
RU2278870C2 |
METHOD FOR LARGE-SCALE PRODUCTION, SEPARATION AND PURIFICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2010 |
|
RU2487885C2 |
METHOD FOR EXTRACTING AND PURIFYING RECOMBINANT PROTEIN, AN ANALOGUE OF A HUMAN KAPPA-CASEIN FRAGMENT HAVING CYTOTOXIC ACTIVITY TOWARDS HUMAN CANCER CELLS | 2018 |
|
RU2693251C1 |
Authors
Dates
2008-06-20—Published
2004-11-23—Filed